Bookmark and Share

Athenahealth to Acquire Epocrates (ATHN, EPOC)

athenahealth Inc. (NASDAQ: ATHN), a provider of online services to hospital and doctors, announced on Monday that it has agreed to acquire Epocrates Inc. (NASDAQ: EPOC), a maker of mobile health applications, in a deal estimated at $293 million, as the Watertown-based company looks to expand its traction in electronic records and gain a leading iPhone application.

San Mateo, California-based Epocrates will receive $11.75 a share, which represents a premium of 22 percent over EPOC’s closing stock price on Friday.

With the help of this acquisition, ATHN, which until now processed insurance claims and patient claims, will be able to able to expand its software business, focused on maintaining records and prescribing drugs.

Besides, the acquisition will also bring EPOC app’s strong brand recognition. As of August 2012, EPOC app was used by 338,000 physicians to conscript summaries on drugs.

According to athenahealth’s Chief Executive, Jonathan Bush, no less than 86,000 physicians have downloaded an iPad app developed by Epocrates, launched just a month ago.

While speaking to Boston Herald, Bush said that “Despite all of our good work and awards and client engagement and client satisfaction scores, 70 percent of doctors in the states do not know who we are and what we do.”

“This is totally the opposite case with Epocrates, which has 90 percent awareness and favorability”, adding that [Epocrates] is “far more important bedside diagnostic tool than a stethoscope” according to Boston Herald.

Meanwhile, the CEO also said the Company intends to maintain the bran for the time being.

“We expect to be taking their lead on mobile app development.  We need each other”, said Bush to Boston Herald.

Following the news, shares of both companies climbed on Monday. While shares of athenahealth  gained 2.15 percent, shares of Epocrates skyrocketed 21.41 percent in regular trading.


Leave a Reply

  

  

  

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>


-------------------------------------------------------------------------------------------------------------------------
All stories in DailyStocks.com are for informational purposes only. This is NOT a stock recommendation. This DailyStocks.com story is a daily light analysis featuring a stock with insider buying. With some caveats, insiders purchase a stock because they think the stock is going up. There are other factors to consider such as size of the transaction relative to their compensation and net worth. Sometimes, insiders might be propping a stock price up for future financing. Sometimes, the amount of insider buying are misread or misreported. Each month, DailyStocks releases a a summary of the stocks with insider buying. Sign up for the free monthly newsletter at DailyStocks.com . About Dailystocks.com: DailyStocks.com is the place where you can find stories about stocks with insider buying, where you can educate yourself about stock market investing, and where you can perform the stock search engine analysis – you enter a stock symbol, and you get a resulting page of stock ticker indexed links so that you do not have to type the stock symbol each time.